This section highlights some of the prevalent cancer types, which have reported significant alterations in heparanase, Sulf1, and/or Sulf2 and how these changes in expression correlate with indices of cancer progression such as prognostic indicators, tumor development, metastasis, and survival. This evidence concerns the gene SULF2 and neoplasm.